SIGN UP
LOG IN
MARKET
OPK
OPK
Opko Health
NASDAQ
1.630
+0.030
+1.88%
After Hours: 1.630 0 -0.02% 19:47 12/08 EST
OPEN
1.600
PREV CLOSE
1.600
HIGH
1.630
LOW
1.560
VOLUME
1.11M
TURNOVER
0
52 WEEK HIGH
2.240
52 WEEK LOW
1.000
MARKET CAP
1.26B
P/E (TTM)
-5.9015
1D
5D
1M
3M
1Y
5Y
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
NASDAQ · 2d ago
Insiders continue to buy OPKO Health, Inc. (NASDAQ:OPK) and now own 43% shares
Opko health, inc. Has a total of 52% ownership of the company. The biggest shareholder holds a majority of the stock with a 43% stake. The largest shareholder is the ceo of opko health with a 30% share price. The company has a good track record of insider ownership, but there's more to the story. Opk health is owned by a group of 6 investors, but the company itself has only a small fraction of the shares. The recent insider purchase price of us$537m is a good sign for shareholders of op ko health. But the company could still surprise us with its future growth.
Simply Wall St · 3d ago
Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report?
NASDAQ · 3d ago
Weekly Report: what happened at OPK last week (1127-1201)?
Weekly Report · 6d ago
Weekly Report: what happened at OPK last week (1120-1124)?
Weekly Report · 11/27 09:14
Weekly Report: what happened at OPK last week (1113-1117)?
Weekly Report · 11/20 09:14
1 Penny Stock Insiders Are Buying with Both Hands
NASDAQ · 11/17 20:34
Phillip Frost Buys Handful Of Shares In OPKO Health
Chairman & ceo of opko health, inc. Phillip frost recently bought us$1.3m worth of stock. In the last 12 months the average share price of opk health insiders have bought shares at close to current prices. The company's insiders own 43% of the company. The recent insider purchase is the biggest share purchase in the last year.
Simply Wall St · 11/15 10:10
About OPK
OPKO Health, Inc. is a healthcare company. The Company's segments include diagnostics and pharmaceuticals. The diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. The pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates laboratory divisions, such as BioReference Health, GenPath and GenPath. Its Pharmaceutical Business has one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including pharmaceutical compounds, Oxyntomodulin, Biologics, Factor VIIa-CTP and others. It also owns an active pharmaceutical ingredients manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.
Webull offers OPKO Health Inc stock information, including NASDAQ: OPK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading OPK stock methods without spending real money on the virtual paper trading platform.